Prasugrel Outperforms Ticagrelor in Reducing Mortality and Stroke in Routine Acute Coronary Syndrome Care: JAMA Medha Baranwal10 Dec 2024 3:15 AMGermany: A recent cohort study published in JAMA Network Open has shed light on the comparative outcomes of ticagrelor and prasugrel in treating...
Concomitant administration of prasugrel with cangrelor may lead to drug-drug interaction in patients undergoing PCI Dr. Kamal Kant Kohli24 Aug 2023 4:30 AMUSA: Patients undergoing PCI (percutaneous coronary intervention) showed a drug-drug interaction with concomitant administration of prasugrel with...
Pretreatment with ticagrelor reduces troponin levels in stable CAD patients undergoing PCI Medha Baranwal22 Jun 2023 5:45 AMItaly: Pretreatment with a loading dose of ticagrelor (Brilinta) instead of prasugrel improves post-procedural microvascular function and coronary...
Study Finds New Evidence on Personalized Selection of Antiplatelet Therapy MD Bureau3 Feb 2022 3:30 AMOral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) used in conjunction with aspirin constitute a key strategy for the prevention of...
Ticagrelor doesn't improve acute coronary syndrome compared to Prasugrel: Study MD Editorial Team27 Jan 2022 3:00 AMDelhi: A meta-analysis by Fong L.C.W. and team revealed that ticagrelor did not reduce the primary composite endpoint of myocardial infection (MI),...
Efficacy and safety of ticagrelor versus prasugrel not affected by eGFR in ACS patients: ISAR-REACT 5 trial Medha Baranwal12 Jan 2022 3:30 AMGermany: Results from ISAR-REACT 5 trial have shown that a reduction of estimated glomerular filtration rate (eGFR) is related to increased risk for...
Prasugrel superior to ticagrelor for ACS patients who underwent PCI: JAMA MD Editorial Team19 Oct 2021 3:30 AMGermany: A prespecified subgroup analysis of a randomized clinical trial revealed that among patients with acute coronary syndrome (ACS) who underwent...
Torrent Pharma to get NPPA notice for failing to apply for price fixation of FDCs despite expiry of exemption Farhat Nasim15 Feb 2021 12:41 PMNew Delhi: Noting that Torrent Pharmaceuticals Ltd, being an existing manufacturer of formulations including Fixed-Dose Combination (FDC) of Prasugrel...
Lesser risk of recurrent MI with prasugrel than ticagrelor in STEMI patients: Circulation Medha Baranwal17 Nov 2020 8:45 AMGermany: The use of ticagrelor versus prasugrel in STEMI patients undergoing primary PCI did not lead to significant differences in incidence of...
Reduced-dose prasugrel lowers bleeding risk in elderly ACS patients: Study Medha Baranwal8 Sept 2020 12:30 PMGermany: A reduced dose of prasugrel versus standard dose of ticagrelor helped in maintaining anti-ischemic efficacy in elderly or...
